https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
gression and glycolysis by downregulating MYO6 expression through sponging miR-502-5p, which might provide a theoretical basis in further studying circ_0000231-directed therapy in CRC. Hsa_circ_0000231 knockdown inhibited CRC progression and glycolysis by downregulating MYO6 expression through sponging miR-502-5p, which might provide a theoretical basis in further studying circ_0000231-directed therapy in CRC. We explored whether clinically relevant baseline characteristics of patients with type 2 diabetes can modify the
Beğen
Yorum Yap
Paylaş
